ATEX in the Pharmaceutical Industry

In pharmaceutical production, alcohols are often used as solvents. Solid active substances and explosive auxiliaries can also be used, for example lactose, vitamins, paracetamol, etc.

Laboratories produce drugs by mixing, emulsifying and chemically reacting organic compounds, usually highly flammable.

Furthermore, all raw materials or chemical compounds produced, both final and intermediate, must be specified in detail as they may be the cause of explosion, fire, corrosion or possible penetration into electrical enclosures.

Processes with ATEX risk

Explain your doubts or needs to us and we will guide you towards your solution

Explosion risk

All combustible dusts, combustible gases and flammable liquids (i.e. with flash point below ambient temperature or processing temperature) carry a risk of explosion. The risk level must be evaluated according to the criteria indicated in the UNE EN 60079-10 standard.

All extraction points for sampling and all open-air loading and unloading systems constitute continuous or first-degree emission sources, which according to the ATEX Directive must be reduced to a minimum. In all containment tanks, transport systems and chemical reactors, there are inevitably second-degree emission sources surrounded by zones 2 (when gas or flammable liquid leaks are feared) or by zones 22 (occasional emissions of combustible dusts), whose Extension is determined case by case with the criteria indicated in the standard.

Count on us

Abrir chat
1
💬 ¿Necesitas ayuda?
¿Hablamos?
Hola 👋
¿En qué podemos ayudarte?